Table 2 Clinical features
Feature | Genotype 1 | Genotype 3 | P value* |
|---|---|---|---|
Patients (n) | 18 | 23 | 0.7§ |
Males, n (%) | 13 (68) | 15 (65) | 1§ |
Females, n (%) | 6 (32) | 8 (35) | |
Age (years -/+SD) | 44.6 -/+13.2 | 43.2 -/+10.2 | 0.19¶ |
Risk factors, n (%) | |||
Injecting drug use | 7 (39) | 12 (52) | 0.53§ |
Blood transfusion | 4 (22) | 2 (9) | 0.03§ |
Anti-D immunoglobulin | 4 (22) | 0 (0) | 0.38§ |
Not determined | 3 (17) | 9 (39) | 0.17§ |
Liver enzyme levels | |||
ALT (IU/L -/+SD) | 112.8 -/+122.6 | 107.4 -/+86.3 | 0.34¶ |
AST (IU/L -/+SD) | 66.6 -/+54.8 | 69.2 -/+59.5 | 0.5¶ |
Leukocyte counts | |||
WCC (x 109/L -/+SD) | 5.7 -/+2 | 6.4 -/+2.5 | 0.3¶ |
Neutrophils (x103/μl) | 3.3 -/+1.4 | 3.4 -/+1.7 | 0.99¶ |
Lymphocytes (x103/μl) | 1.8 -/+0.6 | 2.3 -/+1 | 0.06¶ |
Monocytes (x103/μl) | 0.46 -/+0.13 | 0.6 -/+0.3 | 0.17¶ |
Viral load (x106 IU/ml -/+) SD) | 5.6 -/+10.8 | 7.5 -/+1.3 | 0.31¶ |
IL-28B genotype n (%) | |||
CC | 4 (22) | 8 (35) | 0.5§ |
CT/TT | 10 (56) | 9 (39) | 0.36§ |
Not determined | 4 (22) | 6 (26) | 1§ |